$1.12
Gossamer Bio is a biotechnology business based in the US. Gossamer Bio shares (GOSS) are listed on the NASDAQ and all prices are listed in US Dollars. Gossamer Bio employs 135 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Gossamer Bio stock
How to buy Gossamer Bio stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – GOSS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Gossamer Bio stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Gossamer Bio stock price (NASDAQ: GOSS)
Use our graph to track the performance of GOSS stocks over time.Gossamer Bio shares at a glance
Latest market close | $1.09 |
---|---|
52-week range | $0.45 - $1.60 |
50-day moving average | $0.79 |
200-day moving average | $0.89 |
Wall St. target price | $6.42 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.85 |
Is it a good time to buy Gossamer Bio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Gossamer Bio price performance over time
Historical closes compared with the close of $1.09 from 2024-07-25
1 week (2024-07-19) | 5.83% |
---|---|
1 month (2024-06-27) | 14.48% |
3 months (2024-04-26) | 63.17% |
6 months (2024-01-26) | 36.23% |
1 year (2023-07-27) | -9.92% |
---|---|
2 years (2022-07-27) | -90.86% |
3 years (2021-07-27) | 7.59 |
5 years (2019-07-26) | 21.15 |
Gossamer Bio financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -43.76% |
Return on equity TTM | -480.5% |
Profit margin | 0% |
Book value | $0.12 |
Market Capitalization | $233 million |
TTM: trailing 12 months
Gossamer Bio share dividends
We're not expecting Gossamer Bio to pay a dividend over the next 12 months.
Gossamer Bio share price volatility
Over the last 12 months, Gossamer Bio's shares have ranged in value from as little as $0.453 up to $1.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Gossamer Bio's is 1.93. This would suggest that Gossamer Bio's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Gossamer Bio overview
Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc.
Frequently asked questions
nullWhat percentage of Gossamer Bio is owned by insiders or institutions?
Currently 2.954% of Gossamer Bio shares are held by insiders and 87.819% by institutions. How many people work for Gossamer Bio?
Latest data suggests 135 work at Gossamer Bio. When does the fiscal year end for Gossamer Bio?
Gossamer Bio's fiscal year ends in December. Where is Gossamer Bio based?
Gossamer Bio's address is: 3013 Science Park Road, San Diego, CA, United States, 92121 What is Gossamer Bio's ISIN number?
Gossamer Bio's international securities identification number is: US38341P1021 What is Gossamer Bio's CUSIP number?
Gossamer Bio's Committee on Uniform Securities Identification Procedures number is: 38341P102
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question